$BKYI
BIO KEY INTERNATIONAL INC Stock $bkyi

$bkyi Overview Financials Valuation SEC Filings Company Website

2019 Q4 Form 10-K Financial Statement

#000143774921007486 Filed on March 29, 2021

Income Statement

Concept	2019 Q4	2019	2018 Q4
Revenue	$530.0K	$2.268M	$1.720M
YoY Change	-69.19%	-43.94%	-43.79%
Cost Of Revenue	$670.0K	$2.461M	$1.010M
YoY Change	-33.66%	-40.89%	17.44%
Gross Profit	-$130.0K	-$193.7K	$700.0K
YoY Change	-118.57%	61.91%	-68.04%
Gross Profit Margin	-24.53%	-8.54%	40.7%
Selling, General & Admin	$1.690M	$5.037M	$1.750M
YoY Change	-3.43%	-5.57%	25.9%
% of Gross Profit			250.0%
Research & Development	$360.0K	$1.332M	$330.0K
YoY Change	9.09%	-5.92%	0.0%
% of Gross Profit			47.14%
Depreciation & Amortization	$60.00K	$81.85K	-$450.0K
YoY Change	-113.33%	-3.27%	-209.76%
% of Gross Profit			-64.29%
Operating Expenses	$2.040M	$6.368M	$2.090M
YoY Change	-2.39%	-5.64%	21.51%
Operating Profit	-$2.170M	-$1.069M	-$1.390M
YoY Change	56.12%	-1336325.0%	-395.74%
Interest Expense	-$400.0K	$1.069M	$0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net		-$13.52M
YoY Change		96.82%
Pretax Income	-$9.530M	-$14.59M	-$1.380M
YoY Change	590.58%	112.37%	-387.5%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	-$9.530M	-$14.59M	-$1.380M
YoY Change	590.58%	112.39%	-387.5%
Net Earnings / Revenue	-1798.11%	-643.37%	-80.23%
Basic Earnings Per Share
Diluted Earnings Per Share	-$5.294M	-$8.197M	-$788.6K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2019 Q4	2019	2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$590.0K	$590.0K	$320.0K
YoY Change	84.38%	84.38%	10.34%
Cash & Equivalents	$79.01K	$80.00K	$323.9K
Short-Term Investments	$510.0K	$510.0K
Other Short-Term Assets	$110.9K	$110.0K	$56.68K
YoY Change	95.73%	-91.41%	-48.41%
Inventory	$429.1K	$430.0K	$998.8K
Prepaid Expenses
Receivables	$126.0K	$130.0K	$1.574M
Other Receivables	$110.0K	$110.0K	$60.00K
Total Short-Term Assets	$1.366M	$1.370M	$4.229M
YoY Change	-67.69%	-67.61%	-39.7%
LONG-TERM ASSETS
Property, Plant & Equipment	$95.51K	$660.0K	$148.6K
YoY Change	-35.73%	340.0%	-17.97%
Goodwill
YoY Change
Intangibles	$154.4K		$195.9K
YoY Change	-21.19%		8.17%
Long-Term Investments
YoY Change
Other Assets	$240.0K	$240.0K	$330.0K
YoY Change	-27.27%	-27.27%	3200.0%
Total Long-Term Assets	$1.130M	$1.130M	$7.463M
YoY Change	-84.85%	-84.85%	-17.67%
TOTAL ASSETS
Total Short-Term Assets	$1.366M	$1.370M	$4.229M
Total Long-Term Assets	$1.130M	$1.130M	$7.463M
Total Assets	$2.497M	$2.500M	$11.69M
YoY Change	-78.65%	-78.61%	-27.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$844.6K	$920.0K	$481.3K
YoY Change	75.49%	91.67%	-3.6%
Accrued Expenses	$572.9K	$860.0K	$548.2K
YoY Change	4.5%	56.36%	-20.32%
Deferred Revenue	$359.2K		$196.6K
YoY Change	82.7%		-61.29%
Short-Term Debt		$2.260M	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.391M	$4.390M	$1.226M
YoY Change	258.16%	256.91%	-47.28%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$390.0K	$390.0K
YoY Change
Total Long-Term Liabilities	$390.5K	$390.0K	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.391M	$4.390M	$1.226M
Total Long-Term Liabilities	$390.5K	$390.0K	$0.00
Total Liabilities	$4.782M	$4.780M	$1.226M
YoY Change	290.0%	288.62%	-47.28%
SHAREHOLDERS EQUITY
Retained Earnings	-$89.72M		-$75.13M
YoY Change	19.42%		12.01%
Common Stock	$182.00		$1.398K
YoY Change	-86.98%		81.79%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$2.285M	-$2.290M	$10.47M
YoY Change
Total Liabilities & Shareholders Equity	$2.497M	$2.500M	$11.69M
YoY Change	-78.65%	-78.61%	-27.28%

Cashflow Statement

Concept	2019 Q4	2019	2018 Q4
OPERATING ACTIVITIES
Net Income	-$9.530M	-$14.59M	-$1.380M
YoY Change	590.58%	112.39%	-387.5%
Depreciation, Depletion And Amortization	$60.00K	$81.85K	-$450.0K
YoY Change	-113.33%	-3.27%	-209.76%
Cash From Operating Activities	$30.00K	-$1.850M	-$690.0K
YoY Change	-104.35%	14.68%	2.99%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$28.75K	$30.00K
YoY Change	-100.0%	-44.77%	0.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$510.0K	-$30.00K
YoY Change	-100.0%	1600.0%	-50.0%
Cash From Investing Activities	$0.00	-$543.3K	$0.00
YoY Change		558.89%	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00
YoY Change		-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-30.00K	2.149M	-30.00K
YoY Change	0.0%	24.12%
NET CHANGE
Cash From Operating Activities	30.00K	-1.850M	-690.0K
Cash From Investing Activities	0.000	-543.3K	0.000
Cash From Financing Activities	-30.00K	2.149M	-30.00K
Net Change In Cash	-0.0000000004402	-244.9K	-720.0K
YoY Change	-100.0%	-795.39%	2.86%
FREE CASH FLOW
Cash From Operating Activities	$30.00K	-$1.850M	-$690.0K
Capital Expenditures	$0.00	$28.75K	$30.00K
Free Cash Flow	$30.00K	-$1.879M	-$720.0K
YoY Change	-104.17%	12.82%	2.86%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2019	bkyi	Effective Income Tax Reconciliation Effect Of Net Operating Loss EffectiveIncomeTaxReconciliationEffectOfNetOperatingLoss	-0.19
CY2020	bkyi	Effective Income Tax Reconciliation Permanent Differences EffectiveIncomeTaxReconciliationPermanentDifferences	-0.09
CY2019	bkyi	Effective Income Tax Reconciliation Permanent Differences EffectiveIncomeTaxReconciliationPermanentDifferences	-0.02
CY2020Q4	bkyi	Factored Accounts Receivable Factored Amount FactoredAccountsReceivableFactoredAmount	181262
CY2019Q4	bkyi	Factored Accounts Receivable Factored Amount FactoredAccountsReceivableFactoredAmount	122064
CY2020Q4	bkyi	Accrued Factoring Fees Current AccruedFactoringFeesCurrent	5495
CY2019Q4	bkyi	Accrued Factoring Fees Current AccruedFactoringFeesCurrent	31458
CY2019	bkyi	Adjustments To Additional Paid In Capital Legal And Commitment Fees AdjustmentsToAdditionalPaidInCapitalLegalAndCommitmentFees	301077
CY2020	bkyi	Adjustments To Additional Paid In Capital Legal And Commitment Fees AdjustmentsToAdditionalPaidInCapitalLegalAndCommitmentFees	2371223
CY2019	bkyi	Adjustments To Additional Paid In Capital Warrant Debt Discount Valuation AdjustmentsToAdditionalPaidInCapitalWarrantDebtDiscountValuation	595662
CY2020	bkyi	Amortization Of Beneficial Conversion Feature AmortizationOfBeneficialConversionFeature	641215
CY2019	bkyi	Amortization Of Beneficial Conversion Feature AmortizationOfBeneficialConversionFeature
CY2020	bkyi	Amortization Of Software License Rights AmortizationOfSoftwareLicenseRights
CY2019	bkyi	Amortization Of Software License Rights AmortizationOfSoftwareLicenseRights	843287
CY2020	bkyi	Beneficial Conversion Feature BeneficialConversionFeature	641215
CY2019	bkyi	Beneficial Conversion Feature BeneficialConversionFeature
CY2020	bkyi	Business Combination Accounts Receivable Acquired BusinessCombinationAccountsReceivableAcquired	184792
CY2019	bkyi	Business Combination Accounts Receivable Acquired BusinessCombinationAccountsReceivableAcquired
CY2020	bkyi	Business Combination Accrued Expenses Acquired BusinessCombinationAccruedExpensesAcquired	20017
CY2019	bkyi	Business Combination Accrued Expenses Acquired BusinessCombinationAccruedExpensesAcquired
CY2020	bkyi	Business Combination Deferred Revenue Acquired BusinessCombinationDeferredRevenueAcquired	590000
CY2019	bkyi	Business Combination Deferred Revenue Acquired BusinessCombinationDeferredRevenueAcquired
CY2020	bkyi	Business Combination Equipment Acquired BusinessCombinationEquipmentAcquired	36467
CY2019	bkyi	Business Combination Equipment Acquired BusinessCombinationEquipmentAcquired
CY2020	bkyi	Business Combination Intangible Assets Acquired BusinessCombinationIntangibleAssetsAcquired	1480000
CY2019	bkyi	Business Combination Intangible Assets Acquired BusinessCombinationIntangibleAssetsAcquired
CY2020	bkyi	Business Combination Issuance Of Notes Payable BusinessCombinationIssuanceOfNotesPayable	464000
CY2019	bkyi	Business Combination Issuance Of Notes Payable BusinessCombinationIssuanceOfNotesPayable
CY2020	bkyi	Business Combination Prepaid Expenses Acquired BusinessCombinationPrepaidExpensesAcquired	9485
CY2019	bkyi	Business Combination Prepaid Expenses Acquired BusinessCombinationPrepaidExpensesAcquired
CY2019	bkyi	Class Of Warrant Or Right Grants In Period ClassOfWarrantOrRightGrantsInPeriod	250000
CY2020	bkyi	Class Of Warrant Or Right Increase Due To Trigger Of Antidilution Provision Future ClassOfWarrantOrRightIncreaseDueToTriggerOfAntidilutionProvisionFuture	27244
CY2019Q3	bkyi	Class Of Warrant Or Right Recorded As Debt Discount ClassOfWarrantOrRightRecordedAsDebtDiscount	595662
CY2020	bkyi	Debt Discount Issued With Convertible Note DebtDiscountIssuedWithConvertibleNote
CY2019	bkyi	Debt Discount Issued With Convertible Note DebtDiscountIssuedWithConvertibleNote	550000
CY2020	bkyi	Deemed Dividend Related To Down Round Features DeemedDividendRelatedToDownRoundFeatures
CY2020	bkyi	Effective Income Tax Reconciliation Effect Of Net Operating Loss EffectiveIncomeTaxReconciliationEffectOfNetOperatingLoss	-0.12
CY2020Q4	bkyi	Factored Accounts Receivable Original Invoice Value FactoredAccountsReceivableOriginalInvoiceValue	241715
CY2019Q4	bkyi	Factored Accounts Receivable Original Invoice Value FactoredAccountsReceivableOriginalInvoiceValue	233005
CY2020	bkyi	Factoring Arrangement Minimum Amount Of Accounts Receivable Per Quarter FactoringArrangementMinimumAmountOfAccountsReceivablePerQuarter	150000
	bkyi	Factoring Fees FactoringFees	98748
	bkyi	Factoring Fees FactoringFees	203950
CY2019Q4	bkyi	Finitelived Intangible Assets Writeoff FinitelivedIntangibleAssetsWriteoff	15000
CY2020	bkyi	Government Grant Income GovernmentGrantIncome	340819
CY2019	bkyi	Government Grant Income GovernmentGrantIncome
CY2020	bkyi	Increase Decrease In Capitalized Contract Costs IncreaseDecreaseInCapitalizedContractCosts	86510
CY2019	bkyi	Increase Decrease In Capitalized Contract Costs IncreaseDecreaseInCapitalizedContractCosts	50999
CY2020	bkyi	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-204315
CY2019	bkyi	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-29316
CY2020	bkyi	Increase Decrease In Software License Rights IncreaseDecreaseInSoftwareLicenseRights	-14920
CY2019	bkyi	Increase Decrease In Software License Rights IncreaseDecreaseInSoftwareLicenseRights	-41005
CY2020	bkyi	Operating Lease Liability Assumed Under Asc842 OperatingLeaseLiabilityAssumedUnderAsc842	141761
CY2019	bkyi	Operating Lease Liability Assumed Under Asc842 OperatingLeaseLiabilityAssumedUnderAsc842	707217
CY2020	bkyi	Operational Costs Per Month OperationalCostsPerMonth	735000
CY2019Q3	bkyi	Payments Of Stock Issuance Costs Banker Fees PaymentsOfStockIssuanceCostsBankerFees	193500
CY2019Q3	bkyi	Payments Of Stock Issuance Costs Commitment Fees PaymentsOfStockIssuanceCostsCommitmentFees	50000
CY2019Q3	bkyi	Payments Of Stock Issuance Costs Legal Fees PaymentsOfStockIssuanceCostsLegalFees	71330
CY2020	bkyi	Percentage Of Remaining Balance Owned Reserved PercentageOfRemainingBalanceOwnedReserved	1
CY2020	bkyi	Percentage Of Support And Maintenance Revenue To License Cost PercentageOfSupportAndMaintenanceRevenueToLicenseCost	0.18
CY2020	bkyi	Total Operating Expenses Before Impairment TotalOperatingExpensesBeforeImpairment	7245123
CY2019	bkyi	Total Operating Expenses Before Impairment TotalOperatingExpensesBeforeImpairment	6368487
CY2020	bkyi	Share Based Compensation Excluding Directors Fees ShareBasedCompensationExcludingDirectorsFees	763584
CY2019	bkyi	Share Based Compensation Excluding Directors Fees ShareBasedCompensationExcludingDirectorsFees	912707
CY2020	bkyi	Sharebased Commitment Fees SharebasedCommitmentFees	277833
CY2019	bkyi	Sharebased Commitment Fees SharebasedCommitmentFees	595000
CY2020Q4	bkyi	Software License Rights Noncurrent SoftwareLicenseRightsNoncurrent	58882
CY2019Q4	bkyi	Software License Rights Noncurrent SoftwareLicenseRightsNoncurrent	73802
CY2020	bkyi	Stock Based Fees To Directors And Consultants StockBasedFeesToDirectorsAndConsultants	28511
CY2019	bkyi	Stock Based Fees To Directors And Consultants StockBasedFeesToDirectorsAndConsultants	35013
CY2019Q3	bkyi	Stock Issued During Period Shares Issued For Due Diligence Fee StockIssuedDuringPeriodSharesIssuedForDueDiligenceFee	33334
CY2020Q2	bkyi	Stock Issued During Period Shares Issued For Due Diligence Fee StockIssuedDuringPeriodSharesIssuedForDueDiligenceFee	14368
CY2020Q2	bkyi	Stock Issued During Period Shares Issued For Due Diligence Fee StockIssuedDuringPeriodSharesIssuedForDueDiligenceFee	17071
CY2020Q1	bkyi	Stock Issued During Period Shares Warrants Exercises StockIssuedDuringPeriodSharesWarrantsExercises	121500
CY2019	bkyi	Stock Issued During Period Value Commitment Fees StockIssuedDuringPeriodValueCommitmentFees	595000
CY2020	bkyi	Stock Issued During Period Value Conversion Of Warrant StockIssuedDuringPeriodValueConversionOfWarrant	5602595
CY2019Q3	bkyi	Stock Issued During Period Value Issued For Due Diligence Fee StockIssuedDuringPeriodValueIssuedForDueDiligenceFee	400000
CY2020Q2	bkyi	Stock Issued During Period Value Issued For Due Diligence Fee StockIssuedDuringPeriodValueIssuedForDueDiligenceFee	133333
CY2020Q2	bkyi	Stock Issued During Period Value Issued For Due Diligence Fee StockIssuedDuringPeriodValueIssuedForDueDiligenceFee	100000
CY2020Q3	bkyi	Stock Returned During The Period Shares Commitment Fee StockReturnedDuringThePeriodSharesCommitmentFee	75000
CY2019	bkyi	Total Warrants Exercised TotalWarrantsExercised
CY2019	bkyi	Total Warrants Expired TotalWarrantsExpired	299063
CY2020	bkyi	Total Warrants Expired TotalWarrantsExpired	54066
CY2019	bkyi	Total Warrants Forfeited TotalWarrantsForfeited
CY2020	bkyi	Total Warrants Forfeited TotalWarrantsForfeited
CY2020	bkyi	Warrants Issued With Convertible Notes WarrantsIssuedWithConvertibleNotes	1388339
CY2019	bkyi	Warrants Issued With Convertible Notes WarrantsIssuedWithConvertibleNotes	595662
CY2018Q4	bkyi	Warrants Outstanding Exercise Price WarrantsOutstandingExercisePrice	12.72
CY2019Q4	bkyi	Warrants Outstanding Exercise Price WarrantsOutstandingExercisePrice	12.80
CY2020Q4	bkyi	Warrants Outstanding Exercise Price WarrantsOutstandingExercisePrice	6.04
CY2018	bkyi	Warrants Outstanding Weighted Average Remaining Life WarrantsOutstandingWeightedAverageRemainingLife	P2Y18D
CY2019	bkyi	Warrants Outstanding Weighted Average Remaining Life WarrantsOutstandingWeightedAverageRemainingLife	P3Y343D
CY2020	bkyi	Warrants Outstanding Weighted Average Remaining Life WarrantsOutstandingWeightedAverageRemainingLife	P4Y175D
CY2020	bkyi	Weighted Average Exercise Price Warrant Increase Due To Trigger Of Antidilution Provision Feature WeightedAverageExercisePriceWarrantIncreaseDueToTriggerOfAntidilutionProvisionFeature	5.20
CY2019	bkyi	Weighted Average Exercise Price Warrants Exercised WeightedAverageExercisePriceWarrantsExercised
CY2019	bkyi	Weighted Average Exercise Price Warrants Expired WeightedAverageExercisePriceWarrantsExpired	12
CY2020	bkyi	Weighted Average Exercise Price Warrants Expired WeightedAverageExercisePriceWarrantsExpired	6.86
CY2019	bkyi	Weighted Average Exercise Price Warrants Forfeited WeightedAverageExercisePriceWarrantsForfeited
CY2020	bkyi	Weighted Average Exercise Price Warrants Forfeited WeightedAverageExercisePriceWarrantsForfeited
CY2019	bkyi	Weighted Average Exercise Price Warrants Granted WeightedAverageExercisePriceWarrantsGranted	12
CY2020Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	60453
CY2019Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	110941
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	244158
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	844557
CY2020Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	2281834
CY2019Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	1859785
CY2020Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	561834
CY2019Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	139785
CY2020Q4	us-gaap	Accounts Receivable Gross Noncurrent AccountsReceivableGrossNoncurrent	1720000
CY2019Q4	us-gaap	Accounts Receivable Gross Noncurrent AccountsReceivableGrossNoncurrent	1720000
CY2020Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	548049
CY2019Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	126000
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	548049
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	126000
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	508487
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	572885
CY2020Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	83738
CY2019Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	105933
CY2020Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	87015
CY2019Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	193823
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	929226
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	772304
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	119844026
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	87437661
CY2020	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	641215
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	13785
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Noncurrent AllowanceForDoubtfulAccountsReceivableNoncurrent	1720000
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Noncurrent AllowanceForDoubtfulAccountsReceivableNoncurrent	1720000
CY2020	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1425040
CY2019	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	571332
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2166650
CY2019	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	424980
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	120240
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	43256
CY2019Q4	us-gaap	Asset Impairment Charges AssetImpairmentCharges	6957516
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	912707
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	656008
CY2020	us-gaap	Advertising Expense AdvertisingExpense	494000
CY2019	us-gaap	Advertising Expense AdvertisingExpense	317000
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	792095
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	947720
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1733785
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1733785
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	13785
CY2020Q4	us-gaap	Assets Assets	22520572
CY2019Q4	us-gaap	Assets Assets	2496698
CY2020Q4	us-gaap	Assets Current AssetsCurrent	18941873
CY2019Q4	us-gaap	Assets Current AssetsCurrent	1366291
CY2020Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	3578699
CY2019Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1130407
CY2019Q4	us-gaap	Compensated Absences Liability CompensatedAbsencesLiability	155962
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	474000
CY2020	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	152714
CY2019	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	138679
CY2020Q4	us-gaap	Capitalized Contract Cost Amortization Period CapitalizedContractCostAmortizationPeriod	P4Y
CY2020	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	100747
CY2019	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16993096
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	79013
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	79013
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	323943
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	16993096
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	16914083
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-244930
CY2020Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	16020000
CY2019Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	0
CY2020Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	12
CY2020Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	5.20
CY2018Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	472622
CY2019Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	423559
CY2020Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	4689387
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7814572
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1812483
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7814572
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1812483
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	782
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	182
CY2020Q4	us-gaap	Compensated Absences Liability CompensatedAbsencesLiability	227147
CY2020Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	165315
CY2019Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	231519
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	702336
CY2019Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	359212
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	657349
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	359212
CY2020Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	44987
CY2019Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent
CY2020	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	290000
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	794826
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2461245
CY2020	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
CY2019	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	152000
CY2020Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	65000
CY2019Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	62000
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	13337000
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	15002000
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	81000
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	84000
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1073000
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	894000
CY2020	us-gaap	Dividends Paidinkind DividendsPaidinkind	112686
CY2019	us-gaap	Dividends Paidinkind DividendsPaidinkind
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.08
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-8.21
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	474000
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	15016000
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	16511000
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	14000
CY2019Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	5000
CY2020	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	0
CY2019	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	0
CY2020Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	8712
CY2019Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	8712
CY2020	us-gaap	Depreciation Depreciation	85751
CY2019	us-gaap	Depreciation Depreciation	81852
CY2020Q1	us-gaap	Dividends Paidinkind DividendsPaidinkind	41688
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2020	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y76D
CY2020Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	232547
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	330934
CY2019	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	6957516
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	210694
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1845080
CY2019Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	380080
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1514146
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	154386
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-499076
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt
CY2020Q4	us-gaap	Goodwill Goodwill	1262526
CY2019Q4	us-gaap	Goodwill Goodwill
CY2020	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	1262526
CY2019	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2020	us-gaap	Gross Profit GrossProfit	2041956
CY2019	us-gaap	Gross Profit GrossProfit	-193717
CY2020Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	512821
CY2019Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	512821
CY2020	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-600399
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	438025
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	237257
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	30649
CY2019	us-gaap	Investment Income Interest InvestmentIncomeInterest	154
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-883671
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-84415
CY2019	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	138653
CY2020	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-246876
CY2019	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	162603
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-98172
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-569710
CY2020	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-50488
CY2019	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	54259
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	83625
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-29819
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1514146
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	154386
CY2020	us-gaap	Interest Expense InterestExpense	4343212
CY2019	us-gaap	Interest Expense InterestExpense	1069134
CY2020	us-gaap	Interest Paid Net InterestPaidNet	109426
CY2019	us-gaap	Interest Paid Net InterestPaidNet	72822
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	221130
CY2019Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	287761
CY2020Q4	us-gaap	Inventory Net InventoryNet	330947
CY2019Q4	us-gaap	Inventory Net InventoryNet	429119
CY2020Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	109817
CY2019Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	141358
CY2020	us-gaap	Lease Cost LeaseCost	239192
CY2019	us-gaap	Lease Cost LeaseCost	227781
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-14588700
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-9673987
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9786673
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-14588700
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2229821
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-543310
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4950108
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1850347
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22520572
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2496698
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1876303
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4391405
CY2020Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	309150
CY2019Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	390466
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	533796
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	256977
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	89225
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	187594
CY2020Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	35324
CY2020Q4	us-gaap	Liabilities Liabilities	2185453
CY2019Q4	us-gaap	Liabilities Liabilities	4781871
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	24094012
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2148727
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5203167
CY2020	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	512821
CY2019	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities
CY2020Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1458000
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-13519720
CY2020Q3	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	295000
CY2020Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	295000
CY2019Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent
CY2020Q4	us-gaap	Notes Payable Current NotesPayableCurrent
CY2019Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2255454
CY2020Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent
CY2019Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	188737
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-4470820
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-1068980
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	239192
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	186246
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	498472
CY2019Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	561026
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	234309
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	170560
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	264163
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	390466
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	235186
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	179105
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	487325
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	566479
CY2020	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	220915
CY2019	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	36458
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.055
CY2019Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.055
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y94D
CY2019Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y120D
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	87548
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	68461
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	60453
CY2019Q4	us-gaap	Other Assets Current OtherAssetsCurrent	110941
CY2020	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	2693021
CY2019	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	361273
CY2020	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	2000000
CY2019	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross
CY2020	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	512821
CY2019	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	512821
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets
CY2019	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1736
CY2020	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	295000
CY2019	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	35568
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	28753
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	201507
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	108397
CY2020	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	3958000
CY2019	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	3217000
CY2020	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	22174425
CY2019	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering
CY2019	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	707000
CY2020	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	250000
CY2019	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable
CY2020	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	188737
CY2019	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1396436
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1331667
CY2020Q3	us-gaap	Receivable With Imputed Interest Effective Yield Interest Rate ReceivableWithImputedInterestEffectiveYieldInterestRate	0.05
CY2020	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	5602595
CY2019	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1011019
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	867813
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	81793
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	95509
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts
CY2019	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	564361
CY2020	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	4509250
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-99509689
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-89723016
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2836782
CY2019	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2267528
CY2020Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	17544
CY2019Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	17248
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5848687
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5036820
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.15
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.84
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.003
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0233
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	167980
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	20.77
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	4105
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	15588
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	5598
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	4545
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	28440
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	30167
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	28440
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.16
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	8.24
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	198503
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	218967
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	227274
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	21.76
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	20.08
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	17.61
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0
CY2020	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	39.36
CY2020Q1	us-gaap	Share Price SharePrice	6.08
CY2020Q2	us-gaap	Share Price SharePrice	5.20
CY2020Q4	us-gaap	Share Price SharePrice	3.52
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y182D
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y182D
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y76D
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y317D
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P3Y248D
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	899750
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	891760
CY2020Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	9.28
CY2020Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	5.86
CY2020Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	232000
CY2019Q4	us-gaap	Short Term Borrowings ShortTermBorrowings
CY2020	us-gaap	Short Term Lease Cost ShortTermLeaseCost
CY2019	us-gaap	Short Term Lease Cost ShortTermLeaseCost	41535
CY2020	us-gaap	Stock Issued1 StockIssued1	3789000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	209427
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	18.51
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	24.64
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	29.17
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	18.16
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	17.34
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	9.36
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.04
CY2020	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	3.60
CY2020Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	167980
CY2020Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	227274
CY2019	us-gaap	Stock Issued1 StockIssued1
CY2020Q3	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	38250
CY2020Q4	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	3125
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2019	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised
CY2020	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	3789000
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	277833
CY2020	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
CY2019	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	35013
CY2020	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	28511
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	20335119
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-2285173
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	10466222
CY2020	us-gaap	Sublease Income SubleaseIncome	487325
CY2019	us-gaap	Sublease Income SubleaseIncome	566479
CY2019Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2020Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2020	us-gaap	Use Of Estimates UseOfEstimates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -3pt;"><div style="display: inline; font-style: italic; font: inherit;">2.</div> <div style="display: inline; font-style: italic;">Use of Estimates</div></div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -18pt;"> </div> <div style=" font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt -3pt; text-indent: 18pt;">Our consolidated financial statements are prepared in accordance with GAAP as set forth in the Financial Accounting Standards Board's (FASB) Accounting Standards Codification (ASC) and consider the various staff accounting bulletins and other applicable guidance issued by the U.S. Securities and Exchange Commission (SEC). These accounting principles require us to make certain estimates, judgments and assumptions. The Company believes that the estimates, judgments and assumptions upon which it relies are reasonable based upon information available to us at the time that these estimates, judgments and assumptions are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported amounts of revenues and expenses during the periods presented. Certain significant accounting policies that contain subjective management estimates and assumptions include those related to revenue recognition, accounts receivable, inventory, intangible assets and long-lived assets, and income taxes. To the extent there are material differences between these estimates, judgments or assumptions and actual results, its consolidated financial statements will be affected. In many cases, the accounting treatment of a particular transaction is specifically dictated by GAAP and does <div style="display: inline; font-style: italic; font: inherit;">not</div> require management's judgment in its application. There are also areas in which management's judgment in selecting among available alternatives would <div style="display: inline; font-style: italic; font: inherit;">not</div> produce a materially different result.</div></div></div></div></div></div>
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	4700787
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	1777961

Files In Submission

Name	View Source	Status
R4.htm	Edgar Link	pending
0001437749-21-007486-index-headers.html	Edgar Link	pending
0001437749-21-007486-index.html	Edgar Link	pending
0001437749-21-007486.txt	Edgar Link	pending
0001437749-21-007486-xbrl.zip	Edgar Link	pending
bkyi-20201231.xml	Edgar Link	completed
bkyi-20201231.xsd	Edgar Link	pending
bkyi-20201231_cal.xml	Edgar Link	unprocessable
bkyi-20201231_def.xml	Edgar Link	unprocessable
bkyi-20201231_lab.xml	Edgar Link	unprocessable
bkyi-20201231_pre.xml	Edgar Link	unprocessable
bkyi20201231_10k.htm	Edgar Link	pending
ex_236171.htm	Edgar Link	pending
ex_236648.htm	Edgar Link	pending
ex_236649.htm	Edgar Link	pending
ex_237518.htm	Edgar Link	pending
ex_237519.htm	Edgar Link	pending
ex_237520.htm	Edgar Link	pending
ex_237521.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BKYI
BIO KEY INTERNATIONAL INC Stock $bkyi

2019 Q4 Form 10-K Financial Statement

#000143774921007486 Filed on March 29, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BKYI BIO KEY INTERNATIONAL INC Stock $bkyi

2019 Q4 Form 10-K Financial Statement

#000143774921007486 Filed on March 29, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BKYI
BIO KEY INTERNATIONAL INC Stock $bkyi